Boehringer Ingelheim’s Metacam 20 has been approved in Canada for use in the alleviation of pain and inflammation in sheep. This is the first approval for Metacam 20 in sheep worldwide.
The approval comes following a joint submission from Boehringer Ingelheim in Canada, Australia, and New Zealand that saw regulatory agencies from each country participate in a collaborative review process.
Metacam is a non-steroidal anti-inflammatory drug of the oxicam class. Following the joint submission and review process, it is now licensed for use in sheep in the three countries.